The first Ionis Pharmaceuticals trade was made in Q4 2016.
Since then Joel Greenblatt bought shares ten more times and sold shares on fourteen occasions. The investor completely sold their stake between Q4 2023 and Q1 2025.
Avg closing price
Price range
Sold -6.26 Thousand shares
Q1 2025
Avg closing price
$32.72
Price range
$30.17
-
$34.97
Sold 0.0% shares (-2 shares)
Q4 2024
Avg closing price
$37.31
Price range
$33.73
-
$40.36
Sold 7.7% shares (-524 shares)
Q2 2024
Avg closing price
$41.01
Price range
$36.45
-
$47.70
Sold 2.9% shares (-203 shares)
Q1 2024
Avg closing price
$47.67
Price range
$42.03
-
$53.55
Sold 13.6% shares (-1.1 Thousand shares)
Q4 2023
Avg closing price
$47.90
Price range
$43.39
-
$51.63
Increased shares by 0.3% (+23 shares)
Q3 2023
Avg closing price
$41.26
Price range
$38.50
-
$47.13
Sold 39.1% shares (-5.17 Thousand shares)
Q2 2023
Avg closing price
$38.43
Price range
$34.73
-
$43.33
Sold 81.1% shares (-56.7 Thousand shares)
Q1 2023
Avg closing price
$37.55
Price range
$33.58
-
$41.20
Increased shares by 200.8% (+46.7 Thousand shares)
Q4 2022
Avg closing price
$42.06
Price range
$37.12
-
$46.52
Sold 62.2% shares (-38.2 Thousand shares)
Q3 2022
Avg closing price
$42.14
Price range
$36.54
-
$48.66
Increased shares by 60.0% (+23.1 Thousand shares)
Q2 2022
Avg closing price
$37.71
Price range
$31.71
-
$43.00
New holding (+38.4 Thousand shares)
Q1 2022
Avg closing price
$32.73
Price range
$29.88
-
$37.04
Sold -98 Thousand shares
Q2 2020
Avg closing price
$55.63
Price range
$46.85
-
$61.05
Increased shares by 80.3% (+43.6 Thousand shares)
Q1 2020
Avg closing price
$55.74
Price range
$41.60
-
$63.40
Sold 73.2% shares (-148 Thousand shares)
Q4 2019
Avg closing price
$59.58
Price range
$53.85
-
$65.27
Increased shares by 39.6% (+57.6 Thousand shares)
Q3 2019
Avg closing price
$65.18
Price range
$59.06
-
$72.15
Increased shares by 1179.2% (+134 Thousand shares)
Q2 2019